Bex, A. et al. European Association of Urology guidelines on renal cell carcinoma: the 2025 update. Eur. Urol. 87, 683–696 (2025).

Article  PubMed  Google Scholar 

Powles, T. et al. ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma. Ann. Oncol. 32, 1511–1519 (2021).

Article  CAS  PubMed  Google Scholar 

Campi, R. et al. Could a risk-adapted approach support shared decision-making regarding eligibility for adjuvant pembrolizumab for patients with clear cell renal cell carcinoma at high risk of recurrence? A multicentre cohort study. Eur. Urol. Oncol. 7, 323–327 (2024).

Article  PubMed  Google Scholar 

Marandino, L. et al. Neoadjuvant and adjuvant immune-based approach for renal cell carcinoma: pros, cons, and future directions. Eur. Urol. Oncol. 8, 494–509 (2025).

Article  PubMed  Google Scholar 

Harari, Y. N. 21 Lessons for the 21st Century (Spiegel & Grau, 2018).

Reitblat, C. et al. Value-based healthcare in urology: a collaborative review. Eur. Urol. 79, 571–585 (2021).

Article  PubMed  Google Scholar 

Larcher, A. et al. Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors. Eur. Urol. 88, 341–358 (2025).

Article  CAS  PubMed  Google Scholar 

Fitzgerald, K. N., Motzer, R. J. & Lee, C.-H. Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade. Nat. Rev. Urol. 20, 179–193 (2023).

Article  CAS  PubMed  Google Scholar 

Tannock, I. F., Goldstein, D. A., Ofer, J., Gyawali, B. & Meirson, T. Evaluating trials of adjuvant therapy: is there benefit for people with resected renal cancer? J. Clin. Oncol. 41, 2713–2717 (2023).

Article  PubMed  Google Scholar 

Rossi, S. H. et al. What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An International Neoadjuvant Kidney Cancer Consortium Delphi study. Ann. Oncol. 36, 1231–1234 (2025).

Article  CAS  PubMed  Google Scholar 

Marchioni, M. et al. Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence? Eur. Urol. Open Sci. 46, 39–42 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Grünwald, V. et al. Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: insights from a European delphi study. Eur. J. Cancer 225, 115569 (2025).

Article  PubMed  Google Scholar 

McKay, R. R. et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: expert consensus on the management of renal cell and urinary tract cancers. CA Cancer J. Clin. 76, e70052 (2026).

PubMed  PubMed Central  Google Scholar 

Wilson, B. E. et al. Common sense oncology: equity, value, and outcomes that matter. Am. Soc. Clin. Oncol. Educ. Book 44, e100039 (2024).

Article  PubMed  Google Scholar 

Pecoraro, A. et al. Quality indicators for renal cancer care: a systematic review. Eur. Urol. Oncol. 8, 1416–1427 (2025).

Article  PubMed  Google Scholar